Practice question

Answer the question and get instant feedback.

MediumCardiologyHFrEF (quadruple therapy)ukmlamrcp part 1prescribing safety assessment

A 72-year-old man with HFrEF (EF 30%) on ACEi, beta-blocker, and MRA remains symptomatic. eGFR 60, K⁺ 4.6. Next disease-modifying drug class?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.